ProCE Banner Activity

Expert Answers to Your Questions About Managing Antiplatelet Therapy and Bleeding 

Clinical Thought

In this commentary, an expert addresses key questions from healthcare professionals about managing patients receiving antiplatelet therapy that were posed during a live satellite symposium held at the annual Society of Thoracic Surgeons meeting in January 2025. These responses provide guidance on how to manage bleeding in patients who are being treated with antiplatelet agents, particularly in urgent or emergent surgical settings.

Released: February 19, 2025

Expiration: February 18, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from SERB Pharmaceuticals.

SERB Pharmaceuticals

Disclosure

Primary Author

Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI

Director of Mount Sinai Fuster Heart Hospital
Dr. Valentin Fuster Professor of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI: advisor: Angiowave, Bayer, Boehringer Ingelheim, CellProthera, Cereno Scientific, E-Star Biotech, Janssen, McKinsey, Merck, NirvaMed, Novo Nordisk, Stasys, Tourmaline Bio; individual publicly traded stock/stock options: Angiowave, Bristol Myers Squibb; consultant: Corcept Therapeutics, GlaxoSmithKline, Hims, SFJ, Summa Therapeutics, Youngene; data and safety monitoring committees: Acesion Pharma, Boston Scientific, Contego Medical, Daiichi Sankyo, Novartis; honoraria: Bayer,CSL Behring, Ferring; researcher: 89 Bio, Abbott, Acesion Pharma, Afimmune, Aker Biomarine, Alnylam, Amarin, Amgen, AstraZeneca, Bayer, Beren, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CinCor, Cleerly, CSL Behring, Eisai, Ethicon, Faraday, Ferring, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Javelin, Lexicon, Lilly, Medtronic, Merck, Moderna, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Otsuka, Owkin, Pfizer, PhaseBio, PLx Pharma, Recardio, Regeneron, Roche, Sanofi, Stasys, Synaptic, The Medicines Company, Youngene; other financial or material support: Cleerly.